Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
New-onset heart failure in hemodialysis patients: association with access location and access flow in a nationwide cohort from Sweden
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine.
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine.ORCID iD: 0000-0003-2694-7035
Show others and affiliations
2026 (English)In: Kidney Medicine, E-ISSN 2590-0595, Vol. 8, no 8, article id 101427Article in journal (Refereed) Published
Abstract [en]

Rationale & Objective: There is increasing evidence that arteriovenous fistulas (AVFs) might alter cardiac function. Upper arm AVFs are associated with higher access flow, and their use is increasing. It has been hypothesized that the creation of upper arm AVFs would lead to a higher incidence of heart failure compared with forearm AVFs.

Study Design: Retrospective cohort study.

Setting & Participants: All patients who received a hemodialysis access between 2013 and 2022 in Sweden. Patients with prevalent heart failure or previous hemodialysis were excluded.

Exposure or Predictor: Type of hemodialysis access and access flow.

Outcome: New-onset heart failure.

Analytical Approach: Cox proportional hazards regression for type of access and restricted cubic splines for access flow. Comorbid conditions were included as covariates in both models.

Results: In total, 10,170 patients were included. Of those, 6,579 patients with a total of 11,238 accesses remained after excluding patients with prevalent heart failure or prevalent hemodialysis. The risk of new-onset heart failure was comparable between forearm and upper arm AVF (P = 0.57). Access flow was highest in upper arm AVF (P < 0.001), but there was a substantial overlap. The risk of heart failure development depending on access flow was nonlinear (P < 0.001) with increased risk in patients with lowest as well as the highest flow.

Limitations: Reliance on International Classification of Diseases (ICD)-10 codes is a limitation because of potential underascertainment and misclassification. The findings may not be generalizable to settings where upper arm AVF are used more liberally than in Sweden.

Conclusions: Upper arm AVFs were not associated with the development of heart failure. Comorbid conditions such as ischemic heart disease, heart valve disease, and diabetes as well as age were more important factors for the development of heart failure than access type. The association between access flow and new-onset heart failure is U-shaped.

Place, publisher, year, edition, pages
Elsevier, 2026. Vol. 8, no 8, article id 101427
Keywords [en]
access flow, arteriovenous fistula, heart failure, Long-term hemodialysis, vascular access
National Category
Urology Nephrology Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:umu:diva-256969DOI: 10.1016/j.xkme.2026.101427Scopus ID: 2-s2.0-105045303639OAI: oai:DiVA.org:umu-256969DiVA, id: diva2:2088879
Funder
Region VästerbottenStiftelsen för NjursjukaAvailable from: 2026-07-30 Created: 2026-07-30 Last updated: 2026-10-02Bibliographically approved
In thesis
1. Cardiac implications of haemodialysis and vascular access
Open this publication in new window or tab >>Cardiac implications of haemodialysis and vascular access
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
Hemodialysens och hemodialysaccessens påverkan på hjärtat
Abstract [en]

Background: Patients on haemodialysis have an increased risk for cardiovascular morbidity and premature mortality. This is attributable to both a high burden of traditional risk factors and risk factors associated with kidney failure and the haemodialysis treatment itself. Ultrafiltration and the haemodynamic burden imposed by arteriovenous vascular access is two haemodialysis specific, potentially modifiable risk factors.

Aims: This thesis explores how haemodialysis and haemodialysis access affect cardiac function. The first aim was to examine how the cardiac biomarkers N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitive cardiac Troponin T (TnT) and B-type natriuretic peptide (BNP) are affected by haemodialysis with different dialysers. The second aim was to evaluate if the increase in cardiac biomarkers seen during haemodialysis could be attenuated by changing the ultrafiltration rate. Regarding haemodialysis access, the aim was to study patient specific factors associated with the choice of haemodialysis access and how different access locations and blood flow impact the incidence of heart failure.

Methods: Study I was a prospective, randomised, crossover study. Each patient underwent one session with a low-flux dialyser and one with a high-flux dialyser. Blood samples were collected before treatment, after 180 minutes and at the end of treatment. Using the results from study I, study II was designed as a prospective, crossover, multicentre study. Haemodialysis patients with interdialytic weight gain (IDWG) of more than 2.5% of body weight and an ultrafiltration rate over 0.72 IDWG/h were included. Each participant underwent one session with ordinary dialysis prescription, and one with prolonged treatment time. The goal was to achieve at least a 20% reduction of ultrafiltration rate or ultimately an ultrafiltration rate below 0.6 IDWG/h.

Paper III is a case report describing a patient with highly elevated NT-proBNP caused by a high flow, upper arm arteriovenous fistula (AVF).

Studies IV and V used a retrospective cohort design based on registry data from the Swedish Renal Registry (SRR) and the National Patient Register (NPR). All patients who had a new haemodialysis access registered in the SRR 2013-2022 were included in study IV. In study V, prevalent haemodialysis patients and patients with pre-existing heart failure were excluded. Factors associated with choice of access and subsequent risk of heart failure were assessed in relation to access location and access flow.

Results: Study I included 31 adult, stable haemodialysis patients. Both NT-proBNP and TnT increased during haemodialysis (p<0.001 for both). However, this increase was masked during haemodialysis with high-flux dialyser.

Study II, including 41 patients, confirmed the results from study I (p<0.001 for both markers). However, there was no difference in the increase of cardiac markers between sessions with different ultrafiltration rates (p=0.967 for NT-proBNP and p=0.823 for TnT).

The case reported in Paper III demonstrated that ligation of a high flow arteriovenous fistula can reverse heart failure symptoms and greatly reduce NT-proBNP levels.

In study IV, data on 9706 patients and 17709 accesses was included. The proportion of upper arm fistulas (p=0.042) and arteriovenous grafts (p=0.007) created increased, whilst the proportion of forearm fistulas decreased (p<0.001) during the study period. Factors associated with the choice of haemodialysis access were mainly factors associated with vessel size and vessel quality. In study V, 6579 patients with 11238 accesses were included. There was no difference in risk of heart failure development when comparing different arteriovenous accesses (upper arm AVF HR 0.957 95% CI 0.821-1.115, p=0.57, arteriovenous graft HR 1.044 95% CI 0.842-1.294, p=0.70 with forearm AVF as reference). The risk of heart failure associated with access flow was U-shaped (p<0.001 for non-linearity).

Conclusion: Performing haemodialysis causes cardiac strain that can be measured as increase of cardiac markers. However, reducing the ultrafiltration rate in patients that tolerates their ordinary treatment, does not attenuate this effect. High flow fistulas can cause heart failure, and the use of upper arm fistulas is increasing. The risk of heart failure development is strongly associated with comorbidities. Flow, but not access location itself, impacts heart failure development.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2026. p. 53
Keywords
Haemodialysis, Haemodialysis access, Cardiac biomarkers, Heart failure
National Category
Nephrology
Identifiers
urn:nbn:se:umu:diva-258534 (URN)978-91-6850-067-6 (ISBN)978-91-6850-068-3 (ISBN)
Public defence
2026-10-23, Hörsal Betula, Norrlands universitetssjukhus, Umeå, 13:00 (Swedish)
Opponent
Supervisors
Available from: 2026-10-02 Created: 2026-09-28 Last updated: 2026-10-13Bibliographically approved

Open Access in DiVA

fulltext(981 kB)26 downloads
File information
File name FULLTEXT01.pdfFile size 981 kBChecksum SHA-512
d379f99540e38ece25823692231d8d5d5b431e45ebcc10e3e968990e7c7f298ff424eb9aff62e7de6c7d796393a987b2094e0ca13b1b10651d93b648e4ad1af5
Type fulltextMimetype application/pdf

Other links

Publisher's full textScopus

Authority records

Laveborn, EmelieBergdahl, EllinorStegmayr, BerndOtt, Michael

Search in DiVA

By author/editor
Laveborn, EmelieBergdahl, EllinorStegmayr, BerndOtt, Michael
By organisation
Department of Public Health and Clinical Medicine
In the same journal
Kidney Medicine
UrologyNephrologyCardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar
Total: 26 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 1488 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf